查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
週边血管器械市场规模、份额及成长分析（按类型、应用、最终用户和地区划分）－2026-2033年产业预测
市场调查报告书
商品编码
1899562

週边血管器械市场规模、份额及成长分析（按类型、应用、最终用户和地区划分）－2026-2033年产业预测

Peripheral Vascular Devices Market Size, Share, and Growth Analysis, By Type (Peripheral Stents, PTA Balloons), By Application (Peripheral Arterial Disease (PAD), Aneurysms), By End-Use, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年，週边血管器械市场规模将达到 89.6 亿美元，到 2025 年将达到 94.5 亿美元，到 2033 年将达到 145.1 亿美元，预测期（2026-2033 年）的复合年增长率为 5.5%。

由于血管疾病发生率上升和人口老化加剧，週边血管器械市场正经历强劲增长。创新型器械对于这些疾病的诊断和治疗至关重要，它们能够实现血管成形术和置入术等微创手术，加速患者康復并提高患者舒适度。糖尿病和肥胖等文明病的增加也进一步推动了对有效治疗方案的需求。诊断影像技术的进步和有利的报销政策正在促进市场扩张。然而，严格的监管要求、新兴国家的高成本以及熟练专业人员短缺等挑战可能会阻碍市场成长。关键趋势包括药物释放型球囊、生物可吸收支架和个人化医疗的出现，以及数位健康技术在改善患者预后的应用。

週边血管器械市场驱动因素

心血管疾病，尤其是周边动脉疾病（PAD）和深层静脉栓塞症（DVT）的发生率不断上升，显着推动了周边血管器械市场的成长。心血管疾病是全球主要的死亡原因之一，这表明对有效的诊断和治疗方案的需求日益增长。随着医疗保健系统面临这一日益严峻的挑战，作为疾病管理关键组成部分的周边血管器械的需求持续增长。对高效治疗和改善患者预后的迫切需求，正在推动市场创新和扩张，并进一步影响其整体成长轨迹。

週边血管器械市场的限制因素

由于週边血管器械产品高成本，该市场面临许多限制因素。这些高昂的成本源自于多种因素，包括大规模的研发投入、严格的监管要求以及先进材料和技术的应用。因此，高昂的价格分布可能会阻碍这些器械的广泛应用，尤其是在医疗预算有限、报销体係不完善的发展中地区。这些经济障碍可能会阻碍重要医疗技术的普及，并最终影响到有需要的患者的治疗选择。

週边血管器械市场趋势

週边血管介入器械市场正呈现药物释放型器械应用日益普及的趋势，这类器械在预防血管再阻塞发挥关键作用，从而改善患者预后。这些先进的器械旨在将标靶治疗药物直接输送到受影响的血管，有效降低血管再阻塞的风险和再次手术的需求。透过使用抗增殖药物（例如药物释放型支架中所含的药物），这些产品能够显着减少动脉内瘢痕组织的形成，从而提高血管内治疗的长期成功率。这一趋势凸显了血管治疗领域向创新和以患者为中心的解决方案转变的趋势，也反映了对改善临床疗效的承诺。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管环境
  • 专利分析

全球週边血管器械市场规模（按类型和复合年增长率划分）（2026-2033 年）

  • 外周支架
  • PTA气球
  • 栓塞保护装置
  • 主动脉支架
  • 人工外科移植
  • 慢性完全闭塞治疗装置
  • 其他的

全球週边血管器械市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

  • 周边动脉疾病（PAD）
  • 动脉瘤
  • 静脉疾病

全球週边血管器械市场规模（依最终用途划分）及复合年增长率（2026-2033 年）

  • 医院
  • 门诊手术中心（ASC）
  • 专科诊所
  • 其他的

全球週边血管器械市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Medtronic plc（USA）
  • Boston Scientific Corporation（USA）
  • Abbott Laboratories（USA）
  • Becton, Dickinson and Company（USA）
  • Koninklijke Philips NV（Netherlands）
  • Cook Medical Inc.（USA）
  • Terumo Corporation（Japan）
  • Cardinal Health, Inc.（USA）
  • B. Braun Melsungen AG（Germany）
  • BIOTRONIK SE & Co. KG（Germany）
  • WL Gore & Associates, Inc.（USA）
  • Getinge AB（Sweden）
  • MicroPort Scientific Corporation（China）
  • CryoLife, Inc.（USA）
  • Lombard Medical（UK）
  • Merit Medical Systems, Inc.（USA）
  • Edwards Lifesciences Corporation（USA）
  • Nipro Corporation（Japan）
  • Bluesail Medical Co., Ltd.（China）

结论与建议

简介目录
Product Code: SQMIG35A2529

Peripheral Vascular Devices Market size was valued at USD 8.96 Billion in 2024 and is poised to grow from USD 9.45 Billion in 2025 to USD 14.51 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The Peripheral Vascular Devices market is experiencing robust growth driven by the rising prevalence of vascular diseases and an aging population. Innovative devices are essential for diagnosing and treating these conditions, enabling minimally invasive procedures like angioplasty and stenting, which enhance recovery and patient comfort. The increasing incidence of lifestyle-related illnesses, such as diabetes and obesity, further propels demand for effective treatment solutions. Technological advancements in imaging, coupled with favorable reimbursement policies, support market expansion. However, challenges such as stringent regulatory requirements, high costs in emerging economies, and a shortage of skilled professionals may impede growth. Key trends include the emergence of drug-coated balloons, bioresorbable stents, and personalized medicine, along with the integration of digital health technologies to enhance patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Vascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Vascular Devices Market Segments Analysis

Global Peripheral Vascular Devices Market is segmented by Type, Application, End-Use and region. Based on Type, the market is segmented into Peripheral Stents, PTA Balloons,embolic protection devices, Aortic Stents, Synthetic Surgical Grafts, Chronic Total Occlusion Devices and Others. Based on Application, the market is segmented into Peripheral Arterial Disease (PAD), Aneurysms and Venous Diseases. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Vascular Devices Market

The increasing incidence of cardiovascular conditions, particularly peripheral artery disease (PAD) and deep vein thrombosis (DVT), significantly propels the growth of the peripheral vascular devices market. Cardiovascular diseases are recognized globally as a major cause of mortality, which underscores the heightened necessity for effective diagnostic and therapeutic solutions. As healthcare systems confront this escalating challenge, the demand for peripheral vascular devices continues to rise as a vital component in managing these conditions. The urgency to provide efficient treatments and improve patient outcomes drives innovation and expansion within the market, further influencing its overall growth trajectory.

Restraints in the Peripheral Vascular Devices Market

The peripheral vascular devices market faces a notable constraint due to the elevated costs linked to these products. This expense arises from various factors, including extensive research and development efforts, stringent regulatory compliance, and the incorporation of advanced materials and technologies. As a result, the high price point can hinder the widespread adoption of these devices, especially in developing regions where healthcare budgets are constrained and reimbursement is difficult to navigate. Consequently, such financial barriers may prevent access to these crucial medical advancements, ultimately impacting treatment options for patients in need.

Market Trends of the Peripheral Vascular Devices Market

The peripheral vascular devices market is witnessing an increasing inclination towards drug-eluting devices, which play a crucial role in enhancing patient outcomes by preventing restenosis. These advanced devices are engineered to deliver targeted therapeutic agents directly to affected blood vessels, effectively minimizing the risk of re-narrowing and the necessity for repeat procedures. By employing anti-proliferative drugs, such as those found in drug-eluting stents, these products significantly reduce scar tissue formation within arteries, thereby improving the long-term success rates of vascular interventions. This trend underscores a broader shift towards innovation and patient-centric solutions in vascular care, demonstrating a commitment to better clinical results.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Peripheral Vascular Devices Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Peripheral Stents
  • PTA Balloons
  • Embolic Protection Devices
  • Aortic Stents
  • Synthetic Surgical Grafts
  • Chronic Total Occlusion Devices
  • Others

Global Peripheral Vascular Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Peripheral Arterial Disease (PAD)
  • Aneurysms
  • Venous Diseases

Global Peripheral Vascular Devices Market Size by End-Use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Others

Global Peripheral Vascular Devices Market Size & CAGR (2026-2033)

  • North America (Type, Application, End-Use)
    • US
    • Canada
  • Europe (Type, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lombard Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bluesail Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations